Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_assertion type Assertion NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_head.
- NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_assertion description "[DNA hypermethylation on CpG islands of the p16 (8% and 66%) and hMLH1 (0% and 0%) genes and methylated in tumor (MINT) 1 (6% and 34%), 2 (24% and 58%), 12 (21% and 33%), 25 (0% and 5%), and 31 (0% and 23%) clones, and DNA hypomethylation on satellites 2 and 3 (18% and 67%), were detected in noncancerous liver tissues and HCCs, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_provenance.
- NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_assertion evidence source_evidence_literature NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_provenance.
- NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_assertion SIO_000772 11230735 NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_provenance.
- NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_assertion wasDerivedFrom befree-20140225 NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_provenance.
- NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_assertion wasGeneratedBy ECO_0000203 NP930774.RAasUyT_BkgLvaTNu0HevJ2rqH9cKdZh5M0AmHHt-pck0130_provenance.